Pharmaco-cybernetic Approaches to Patient Safety & Enhancing Risk Communication in the Cybermedicine Age
This presentation from our 2015 event explores the drug-related problems in the cybermedicine age, including the role of pharmaco-informatics, pharmaco-cybernetics in patient safety and strategies to enhance risk communication.
Exploiting Social Media to Identify Potential Safety Signals and to Augment Adverse Event Data Collection
This presentation examines the current global regulations regarding the use of social media to detect potential safety signals, as well as the existing tools and strategies available to do so.
In this presentation, Rie Matsui, Director of Regional Labeling at Pfizer, examines the steps required to align labeling global safety and labelling standards, changes in regulation and future trends in Asia.